Clinical Trials on Skeletal Muscle Fatty Acid Metabolism in South Africa
Total 51 results
-
Cycle Pharmaceuticals Ltd.ParexelCompletedHereditary Tyrosinemia, Type ISouth Africa
-
Cycle Pharmaceuticals Ltd.ParexelCompletedHereditary Tyrosinemia, Type ISouth Africa
-
Cycle Pharmaceuticals Ltd.ParexelCompletedHereditary Tyrosinemia, Type ISouth Africa
-
Medical University of South CarolinaAker Biomarine Antarctic ASCompletedFatty Acids, Omega-3 | Cognition | Nutrition | Resilience, Psychological | Psychology, MilitaryUnited States
-
Baxter Healthcare CorporationTerminatedEssential Fatty Acid Deficiency (EFAD)United States
-
Harokopio UniversityUniversity of Novi Sad; National Research Council, Institute of Clinical Physiology...CompletedNon Alcoholic Fatty Liver DiseaseGreece
-
SangartCompletedShock, Hemorrhagic | Acidosis, Lactic | Shock, TraumaticFrance, United Kingdom, South Africa, Germany
-
ModernaTX, Inc.RecruitingMethylmalonic AcidemiaUnited States, Spain, Canada, Netherlands, France, Australia, United Kingdom
-
Pronova BioPharmaNutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedNon Alcoholic Fatty LiverUnited States
-
PerspectumKing's College Hospital NHS Trust; University of Coimbra; Liverpool University... and other collaboratorsCompletedMetabolic Syndrome | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited Kingdom, Germany, Netherlands, Portugal
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
ModernaTX, Inc.RecruitingPhenylketonuriaUnited States, Australia
-
Jnana TherapeuticsRecruitingPhenylketonuriaUnited States, Australia
-
Australian and New Zealand Intensive Care Research...RecruitingShock | Metabolic AcidosisAustralia, New Zealand, Oman
-
89bio, Inc.ProSciento, Inc.Completed
-
The George InstituteNot yet recruitingDiabetic KetoacidosisAustralia
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
BioMarin PharmaceuticalApproved for marketing
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
SynlogicTerminatedPhenylketonuriaUnited States, Canada, Georgia, Turkey
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
BioMarin PharmaceuticalCompletedPhenylketonuria | HyperphenylalaninaemiaUnited States
-
Aeglea BiotherapeuticsTerminatedHomocystinuria Due to Cystathionine Beta-Synthase DeficiencyUnited States, United Kingdom, Australia
-
SangartCompletedShock, Hemorrhagic | Acidosis, Lactic | Shock, TraumaticNorway, Singapore, Israel, France, United Kingdom, Germany, Switzerland, Australia, Brazil, South Africa, New Zealand, Colombia, Austria, Spain
-
PTC TherapeuticsCompletedPhenylketonuriaSpain, United States, Australia, Germany, United Kingdom, Brazil, Denmark, Canada, France, Georgia, Italy, Mexico, Netherlands, Portugal, Turkey
-
Cardiff and Vale University Health BoardCompletedSepsis | Acute Kidney Injury | Diabetic KetoacidosisUnited Kingdom
-
SangartWithdrawnTrauma | Hemorrhagic Shock | Lactic AcidosisNew Zealand, United Kingdom, Israel, France, Switzerland, Australia, Belgium, Brazil, Germany, Norway, South Africa
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; University of LiverpoolCompleted
-
South Tyneside and Sunderland NHS Foundation TrustNewcastle-upon-Tyne Hospitals NHS Trust; South Tees Hospitals NHS Foundation... and other collaboratorsCompletedObesity | Colorectal Cancer | Metabolic Syndrome | Colorectal Neoplasm | Colorectal Adenoma | Liver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
Institut PasteurUniversity of Copenhagen; Institut CochinCompletedDiarrhea | InfantileFrance, New Caledonia, Central African Republic
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Flex Pharma, Inc.TerminatedMotor Neuron DiseaseUnited States
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Michael Pulsipher, MDRecruiting
-
Tisento TherapeuticsNot yet recruitingMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)United States, Australia, Italy, Germany, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedMuscle Wasting (Atrophy) After Hip Fracture SurgeryColombia, Belgium, Hungary, Taiwan, Spain, Czechia, United States, France, Germany, Turkey, Japan, Russian Federation, United Kingdom, Argentina, Australia, Mexico, Chile, Switzerland, Austria
-
GlaxoSmithKlineParexelCompletedCachexiaGermany, United States, United Kingdom
-
AstraZenecaTerminatedChronic Kidney Disease | Metabolic Acidosis | HyperkalaemiaUnited States, Puerto Rico
-
UK Kidney AssociationRecruitingVasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditionsUnited Kingdom
-
GTxCompletedNon-Small Cell Lung Cancer | Muscle WastingUnited States
-
GTxCompletedNon Small Cell Lung Cancer | Muscle WastingUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia
-
Atara BiotherapeuticsRecruitingLymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditionsUnited States, Austria, Belgium, France, Italy, Spain, United Kingdom